NutriBand (NTRB) Non-Current Assets (2017 - 2026)
NutriBand's (NTRB) quarterly Non-Current Assets came in at $2.6 million in Q1 2026, down 4.35% year-on-year from $2.7 million in Q1 2025, and down 1.72% quarter-over-quarter from $2.6 million in Q4 2025.
NutriBand (NTRB) Non-Current Assets (2017 - 2026) Analysis & Trends
NutriBand has disclosed Non-Current Assets across 10 years of filings, most recently posting $2.6 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $2.6 million, down 4.35% year-over-year; the trailing twelve-month figure through Jan 2026 was $10.5 million (down 51.73% YoY), and the FY2026 annual result was $2.6 million, down 4.35% from the prior year.
- Non-Current Assets came in at $2.6 million for Q1 2026 at NutriBand, down from $2.6 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $7.3 million in Q2 2022 to a low of $2.6 million in Q1 2026.
- The 5-year median for Non-Current Assets is $6.5 million (2024), against an average of $5.6 million.
- Across the five-year window, Non-Current Assets retreated 2.63% in 2024 and slumped 59.0% in 2025, its largest moves.
- NutriBand's Non-Current Assets stood at $7.2 million in 2022, then declined by 8.92% to $6.5 million in 2023, then fell by 2.63% to $6.4 million in 2024, then plunged by 59.0% to $2.6 million in 2025, then slipped by 1.72% to $2.6 million in 2026.
- The last three Non-Current Assets figures came in at $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 39.71 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 2.56 Mn |
| Oct 31, 2025 | 2.60 Mn |
| Jul 31, 2025 | 2.66 Mn |
| Apr 30, 2025 | 2.72 Mn |
| Jan 31, 2025 | 2.68 Mn |
| Oct 31, 2024 | 6.35 Mn |
| Jul 31, 2024 | 6.39 Mn |
| Apr 30, 2024 | 6.42 Mn |
| Jan 31, 2024 | 6.50 Mn |
| Oct 31, 2023 | 6.52 Mn |
| Jul 31, 2023 | 6.60 Mn |
| Apr 30, 2023 | 6.68 Mn |
| Jan 31, 2023 | 6.76 Mn |
| Oct 31, 2022 | 7.16 Mn |
| Jul 31, 2022 | 7.27 Mn |
| Apr 30, 2022 | 7.34 Mn |
| Jan 31, 2022 | 7.27 Mn |
| Oct 31, 2021 | 9.48 Mn |
| Jul 31, 2021 | 9.56 Mn |
| Apr 30, 2021 | 9.63 Mn |